MetLife Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $225K | Hold |
|
|||||
|
2025
Q1 | $216K | Sell |
|
|||||
|
2024
Q4 | $206K | Buy |
|
|||||
|
2024
Q3 | $166K | Sell |
|
|||||
|
2024
Q2 | $84.2K | Buy |
|
|||||
|
2024
Q1 | $107K | Sell |
|
|||||
|
2023
Q4 | $134K | Hold |
|
|||||
|
2023
Q3 | $100K | Hold |
|
|||||
|
2023
Q2 | $120K | Hold |
|
|||||
|
2023
Q1 | $122K | Buy |
|
|||||
|
2022
Q4 | $97.2K | Sell |
|
|||||
|
2022
Q3 | $113K | Buy |
|
|||||
|
2022
Q2 | $8.72K | Sell |
|
|||||
|
2022
Q1 | $256K | Buy |
|
|||||
|
2021
Q4 | $78.4K | Sell |
|
|||||
|
2021
Q3 | $223K | Buy |
|
|||||
|
2021
Q2 | $181K | Sell |
|
|||||
|
2021
Q1 | $237K | Buy |
|
|||||
|
2020
Q4 | $167K | Buy |
|
|||||
|
2020
Q3 | $113K | Sell |
|
|||||
|
2020
Q2 | $148K | Buy |
|
|||||
|
2020
Q1 | $62K | Sell |
|
|||||
|
2019
Q4 | $178K | Buy |
|
|||||
|
2019
Q3 | $25.9K | Sell |
|
|||||
|
2019
Q2 | $280K | Buy |
|
|||||
|
2019
Q1 | $175K | Hold |
|
|||||
|
2018
Q4 | $157K | Hold |
|
|||||
|
2018
Q3 | $219K | Sell |
|
|||||
|
2018
Q2 | $287K | Buy |
|
|||||
|
2018
Q1 | $235K | Hold |
|
|||||
|
2017
Q4 | $257K | Buy |
|